Clinical trial
Efficacy and Safety of Sequential IV/PO Moxifloxacin in Comparison to IV…
NCT00431678 · Bayer, Industry · Completed
Key facts
| NCT number | NCT00431678 |
|---|---|
| Title | Efficacy and Safety of Sequential IV/PO Moxifloxacin in Comparison to IV Levofloxacin Plus IV Ceftriaxone Followed by PO Levofloxacin, in the Treatment of Patients With Community-acquired Pneumonia |
| Official title | A Multinational, Prospective, Randomized, Double-blind Study to Investigate the Efficacy and Safety of Sequential Intravenous/Oral Moxifloxacin in Comparison to Intravenous Levofloxacin Plus Intravenous Ceftriaxone Followed by Oral Levofloxacin, in the Treatment of Patients With Severe… |
| Lead sponsor | Bayer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pneumonia |
| Intervention type | Drug |
| Interventions | Avelox (Moxifloxacin, BAY12-8039), Levofloxacin + Ceftriaxone |
| Enrollment | 738 |
| Start date | Jan 1, 2004 |
| Primary completion | Jul 1, 2005 |
| Completion | Jul 1, 2005 |
| First posted | Feb 6, 2007 |
| Last update posted | Dec 17, 2014 |
| Countries | Argentina, Belgium, Chile, Colombia, France, Germany, Greece, Israel, Lithuania, Mexico, Netherlands, Peru and 6 more |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: